| 1 |
Hen-Shoval D, Moshe L, Indig-Naimer T, Mechoulam R, Shoval G, Zalsman G, Kogan NM, Weller A. Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats. Int J Mol Sci 2023;24. [PMID: 36835237 DOI: 10.3390/ijms24043828] [Reference Citation Analysis]
|
| 2 |
Tanaka M, Zhang Y. Preclinical Studies of Posttraumatic Headache and the Potential Therapeutics. Cells 2022;12. [PMID: 36611947 DOI: 10.3390/cells12010155] [Reference Citation Analysis]
|
| 3 |
Kumar S, Ramasamy K, Chandra Sistla S, Penumadu P, Natarajan H, Chakradhara Rao US, Nair S, Vasuki V, Kundra P. Predictive models for fentanyl dose requirement and postoperative pain using clinical and genetic factors in patients undergoing major breast surgery. Pain 2022. [PMID: 36701226 DOI: 10.1097/j.pain.0000000000002821] [Reference Citation Analysis]
|
| 4 |
Bouchet CA, Janowsky A, Ingram SL. Persistent inflammation promotes endocannabinoid release and presynaptic cannabinoid 1 receptor desensitization.. [DOI: 10.1101/2022.06.20.496891] [Reference Citation Analysis]
|
| 5 |
He B, Di X, Guled F, Harder AV, van den Maagdenberg AM, Terwindt GM, Krekels EH, Kohler I, Harms A, Ramautar R, Hankemeier T. Quantification of endocannabinoids in human cerebrospinal fluid using a novel micro-flow liquid chromatography-mass spectrometry method. Analytica Chimica Acta 2022;1210:339888. [DOI: 10.1016/j.aca.2022.339888] [Reference Citation Analysis]
|
| 6 |
Zubrzycki M, Zubrzycka M, Wysiadecki G, Szemraj J, Jerczynska H, Stasiolek M. Effect of Fatty Acid Amide Hydrolase Inhibitor URB597 on Orofacial Pain Perception in Rats. IJMS 2022;23:4665. [DOI: 10.3390/ijms23094665] [Reference Citation Analysis]
|
| 7 |
Della Pietra A, Savinainen J, Giniatullin R. Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain. Int J Mol Sci 2022;23:4407. [PMID: 35457225 DOI: 10.3390/ijms23084407] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Jaiswal S, Akhilesh, Uniyal A, Tiwari V, Raja Ayyannan S. Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones. Bioorg Med Chem 2022;60:116698. [PMID: 35296453 DOI: 10.1016/j.bmc.2022.116698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Lo Castro F, Baraldi C, Pellesi L, Guerzoni S. Clinical Evidence of Cannabinoids in Migraine: A Narrative Review. J Clin Med 2022;11:1479. [PMID: 35329806 DOI: 10.3390/jcm11061479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Greco R, Demartini C, Zanaboni AM, Francavilla M, De Icco R, Ahmad L, Tassorelli C. The endocannabinoid system and related lipids as potential targets for the treatment of migraine-related pain. Headache 2022;62:227-40. [PMID: 35179780 DOI: 10.1111/head.14267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Giniatullin R. 5-hydroxytryptamine in migraine: The puzzling role of ionotropic 5-HT3 receptor in the context of established therapeutic effect of metabotropic 5-HT1 subtypes. Br J Pharmacol 2021. [PMID: 34643938 DOI: 10.1111/bph.15710] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
